SMYD3 has been demonstrated to play an important role in esophageal squamous cell carcinoma, gastric carcinoma, hepatocellular carcinoma, breast carcinoma, etc.8 However, whether SMYD3 expression contributes to ovarian cancer development and progression is still unknown. Here, SMYD3 is linked to hepatocellular carcinoma.